Akebia Therapeutics Inc. AKBA) on Thursday reported a fourth-quarter loss of $22.8 million, after reporting a profit in the same period a year earlier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback